生酮与非生酮减重饮食对MASLD肝脂肪变及线粒体代谢的不同影响
该交叉设计研究比较了短期低热量生酮饮食(KD)与非生酮饮食(ND)对MASLD患者肝内甘油三酯(IHTG)和肝脏线粒体代谢的影响。尽管能量缺口和体脂减少相似,KD使IHTG多降低45%(-29% vs -20%),肝胰岛素敏感性改善三倍(59% vs 21%),但KD独特地增加肝脏线粒体 redox 状态并抑制TCA循环氧化。结论提示KD虽更有效减少肝脂肪,但伴随既往与肝损伤进展相关的代谢特征。
要点
- 短期低热量KD较ND多降低IHTG 45%(-29% vs -20%),肝胰岛素敏感性改善更显著(59% vs 21%)。
- KD独特地降低血清胰岛素54%,增加肝脏线粒体[NADH]/[NAD+] 51%,降低TCA循环氧化34%。
- KD的获益伴随既往与进行性肝损伤相关的代谢特征,晚期MASLD患者需谨慎使用。
核心结论
- KD与ND均改善MASLD,但KD通过类饥饿代谢状态更大幅度降低IHTG,同时伴随线粒体 redox 状态升高和TCA循环氧化抑制。
研究设计与样本
- 采用交叉设计,对IHTG含量不同的个体进行短期低热量KD和ND干预,使用质子磁共振波谱定量IHTG,磁共振弹性成像评估肝硬度,同位素示踪法比较肝脏线粒体TCA循环氧化、内源性葡萄糖生成和β-羟丁酸生成率,NMR和LC-MS进行靶向血浆代谢组学。
主要发现
- 尽管能量缺口和体脂减少相似,KD使IHTG降低29%,ND降低20%,KD多降低45%。
- KD使肝胰岛素敏感性改善59%,ND改善21%,KD改善幅度为ND的三倍。
- KD使血清胰岛素降低54%,增加肝脏线粒体[NADH]/[NAD+] 51%,降低TCA循环氧化34%。
- KD增加血浆支链氨基酸、酰基肉碱和TCA循环中间产物浓度,ND无此效应。
临床怎么用
- 在特定临床情境下KD可促进肝脏脂肪快速减少,但需谨慎使用,尤其对晚期MASLD患者。
- 制定MASLD营养干预时,除热量限制外应考虑饮食成分对疗效和安全性的影响。
局限性
- 研究为短期干预,长期效果和安全性未评估。
- 样本为IHTG含量不同的个体,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Weight loss is the cornerstone of therapy for metabolic dysfunction-associated steatotic liver disease (MASLD). However, the optimal dietary approach for reducing intrahepatic triglycerides (IHTG) and the mechanisms underlying steatosis resolution remain poorly defined. We investigated whether weight loss via a ketogenic diet (KD) compared with a non-ketogenic diet (ND) differentially affects IHTG content, hepatic mitochondrial metabolism, and the circulating metabolome. METHODS: Individuals with varying IHTG content underwent short-term hypocaloric KD and ND in a crossover design. Before and after each diet, IHTG was quantified by proton magnetic resonance spectroscopy and liver stiffness by magnetic resonance elastography. We used state-of-the-art isotope tracer methodology to compare in vivo rates of hepatic mitochondrial tricarboxylic acid (TCA) cycle oxidation, endogenous glucose production, and β-hydroxybutyrate production (ketogenesis). Targeted plasma metabolomics by NMR and LC-MS was used to evaluate systemic metabolic responses. RESULTS: Despite similar energy deficits and body fat loss, IHTG decreased 45% more with KD than ND (-29% vs. -20%), accompanied by a threefold greater improvement in hepatic insulin sensitivity (59% vs. 21%). KD, but not ND, markedly reduced serum insulin concentrations (-54%), thereby promoting lipolysis and intrahepatic fatty acid partitioning toward mitochondrial β-oxidation, increasing hepatic mitochondrial [NADH]/[NAD+] (redox state) (+51%), and decreasing rates of hepatic mitochondrial TCA cycle oxidation (-34%). KD, but not ND, increased plasma concentrations of branched-chain amino acids, acylcarnitines, and TCA cycle intermediates. CONCLUSIONS: Both diets ameliorated MASLD, but KD produced a greater reduction in IHTG owing to a starvation-like metabolic state. However, the benefits of KD were accompanied by increased hepatic mitochondrial redox state and suppression of TCA cycle oxidation, which are features previously linked to progressive liver injury. IMPACT AND IMPLICATIONS: This study provides mechanistic justification for considering dietary composition, in addition to caloric restriction, as a key determinant of steatosis resolution in metabolic dysfunction-associated steatotic liver disease (MASLD). The findings highlight a potential trade-off between greater short-term reductions in liver fat and the emergence of metabolic features previously associated with increased susceptibility to liver injury. While a ketogenic diet may facilitate rapid liver fat reduction in selected clinical contexts, its use should be approached cautiously, particularly in individuals with advanced MASLD. These results underscore the need for systematic evaluation of dietary composition as a determinant of both efficacy and safety of nutritional interventions for MASLD. CLINICAL TRIAL NUMBER: NCT03737071.
引用
- Qadri SF, Porthan K, Dufour S, et al. Distinct effects of ketogenic and non-ketogenic weight-loss diets on hepatic steatosis and mitochondrial metabolism in MASLD. J Hepatol. 2026. PMID: 41655910. doi:10.1016/j.jhep.2026.02.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。